Vectus Biosystems Limited [ASX:VBS] share price and news 2022

Company Description

Vectus Biosystems Limited (VBS) is a public company based at Julius Avenue, North Ryde, Sydney, Australia. Vectus has developed potentially novel treatments for fibrosis and high blood pressure, which include treatment for three of the largest diseases in the fibrotic franchise, namely heart, kidney and liver disease.

Vectus Biosystems Limited belongs to Health Care sector and under industry of Biotechnology. You can get more information about this company via their website: http://www.vectusbiosystems.com.au.

This a small cap company with market cap of 39 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while Company PB is less than both sector and market. On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 -5.24 0
Market 0.85 22.3 1.99 0.84
Sector 1.7 39.6 5.78 0.26

Dividend Growth Chart

The following chart shows you how vbs dividend grows in the recent years.

No data